For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

This study found that treatment with inebilizumab greatly reduced the symptoms of immunoglobulin G4–related disease (IgG4-RD), compared to placebo.

Dr, Garner said, "Glucagon-like peptide-1 (GLP-1) receptor agonists represent a significant advancement in the treatment of ...

Manoj Chowdary Vattikuti, Sr. DevOps Engineer at Cardinal Health, and Niharikareddy Meenigea, Sr. Data Analyst at Virginia ...

Diabetes mellitus is a chronic metabolic disorder in which the body is not able to control the blood glucose levels in the ...

This review explores the role of lysosomal stress in pancreatic diseases, particularly diabetes mellitus. Lysosomes, crucial ...

During his lecture “Dermatologic Manifestations of Systemic Diseases” presented at the New York Vet show in New York, New ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Diabetes, also known as diabetes mellitus, has been described in literature dating back centuries. 3 In ancient Egyptian papyri, patients were described as having excessive thirst and urination.

Researchers from the TEDDY study highlight how specific genetic and environmental factors may drive early autoimmunity linked ...